Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment

Our investigation suggested that gait speed and step length are key indicators for fall risk. Compared to controls, cancer patients with CIPN may display slower gait velocities, shorter step length, and are at an increased fall risk as indicated by TUG scores. The presence of CIPN appears to increase fall risk, which may easily be assessed in a clinical setting using the TUG test.